People · Operator
Named in public records as an officer, director or promoter · active 2010–2016 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Semprae Laboratories Inc | — | Other | Series A | $8.2M | $62.0M | 2010 |
| Formula XO, Inc. | — | Other | Pre-Seed | $1.2M | $2.3M | 2014 |
Rachel Braun Scherl at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rachel Braun Scherl on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Adele C. Oliva | 1 | 5 |
| Michael Zasloff | 1 | 2 |
| William Oetgen | 1 | 2 |
| Mary Wallace Jaensch | 1 | 1 |
| David Glick | 1 | 1 |
| Wayne Willis | 1 | 1 |
| Lucinda C. Holt | 1 | 1 |
| Mario Braun Russo | 1 | 1 |
| Stacie C. Mullen | 1 | 1 |
| Camille C. Samuels | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.